By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex and the Tecan Group today announced a collaboration to develop new automated screening platform for the faster detection of potential health risks in newborns.

The global original equipment manufacturing agreement will combine Luminex's xMAP technology and LX200 instrument with Tecan's Freedom EVO liquid handling platform and HydroFlex Washer.

Terms of the deal were not announced.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.